With a team of experienced research nurses and study coordinators, highly experienced Principal and Associate Investigators and a dedicated Research Fellow, we actively participate in a broad range of early phase national and international clinical trials (commercially sponsored and investigator-lead) as well as leading our own research. The Renal Research Unit has full capability to conduct Phase I-IV interventional trials across a broad range of chronic disease disciplines.
We collaborate with many Australian and International Pharmaceutical companies, Contract Research Organisations and network research groups to trial new and adjunct therapies in Renal, Diabetic and Cardiac disease.
Our partners include the Australian Kidney TrialsNetwork, The George Institute, Baker Heart and Diabetes Research Group to contribute to trialling new therapies and adjunct therapies.
Current active investigator initiated clinical trials:
ACHIEVE: Aldosterone bloCkade for Helath Improvement EValuation in End-stage Renal Disease. Sponsor: Population Health Research Institute Canada Principal Investigator: Prof Eugenia Pedagogos
TRACK: Randomised, double-blind, placebo-controlled trial in the treatment of CVD with low dose Rivaroxaban in Advanced CKD. Sponsor: The George Institute Australia Principal Investigator: Dr Adam Flavell
GLOBAL KIDNEY PATIENT TRIALS NETWORK: A prospective observational cohort study of incident and prevalent patients diagnosed with a kidney disease. Sponsor: The George Institute Australia Principal Investigator: Dr Adam Flavell
GOAL: Comprehensive geriatric assessment for frail older people with Chronic Kidney Disease to increase attainment of patient-identified goals – A cluster randomised controlled trial. Sponsor: Australasian Kidney Trials Network Principal Investigator: Dr Leny Hidayati
Page last updated November 2022